SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Papa John's International, Inc. engages in the operation and franchise of pizza delivery and carryout restaurants. It operates through the following segments: Domestic Company-owned Restaurants, North America Franchising, North America Commissaries, International Operations, and All Others. The Domestic Company-Owned Restaurants segment consists of retail sales of pizza and side items, breadsticks, cheese sticks, chicken poppers and wings, dessert items, and canned and bottled beverages. The North America Franchising segment involves the offering of sales and support activities, development rights, and collection of royalties from franchisees located in the United States and Canada. The North America Commissaries segment includes the eleven full-service regional dough production and distribution and quality control centers. The International Operations segment represents all restaurant operations outside of the United States and Canada. The All Others segment focuses on franchise contributions to marketing funds and sale, company-owned and franchised restaurants, information systems and related services used in restaurant operations, point-of-sale system, online and other technology-based ordering platforms, printing, and promotional items. The company was founded by John H. Schnatter in 1984 and is headquartered in Louisville, KY.

Papa John`s International, Inc.

Take-private speculation is the dominant topic, centered on Irth Capitals reported bid and a major U.S. franchisee joining the effort; traders are debating whether a deal will materialize, with no confirmed agreement in the discussion. The takeover hopes contrast with criticism of management and concern over weak sales, a dividend suspension, and the stocks steep decline.

TOSHI

Renewed volume and choppy price action have traders watching for a breakout in TOSHI, with bullish posts anticipating a rally or short squeeze while skeptics point to repeated resistance and the risk of further lows. The discussion is largely speculative technical trading and community conviction around the Base meme coin, with no confirmed new catalyst dominating.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

SHIB is drawing attention for choppy, largely sideways trading, with repeated technical posts describing consolidation and traders watching for a breakout. Optimistic holders are accumulating and anticipating a rebound, while skeptics point to the tokens lack of momentum and utility and expect further weakness.

ProShares Trust II - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

UCO is drawing attention as crude oil rises amid Middle East tensions and fears of supply disruptions around the Strait of Hormuz. Bullish traders point to supply risks, while others warn that easing tensions or renewed diplomacy could trigger a pullback.

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Celcuity Inc

New ESMO subgroup analyses from Celcuitys Phase 3 VIKTORIA-1 breast cancer study are drawing attention, with traders highlighting promising efficacy while noting the topline results were already known. The community is split on whether the update adds a fresh catalyst, with discussion also focused on the FDA review of the PIK3CA-mutant label expansion and the need to demonstrate commercial sales.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Amgens Phase 3 lung-cancer data for IMDELLTRA combined with AstraZenecas IMFINZI is drawing attention after showing a substantial survival benefit in extensive-stage small-cell lung cancer. Traders view the results as a potential growth driver for Amgens oncology pipeline, while also weighing established products such as Repatha and treating the companys AI story as a longer-term theme.

Select Sector SPDR Trust (The) - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

XLE is drawing attention after reaching a new high as energy stocks outperform, with traders pointing to rising crude prices and supply risks tied to Middle East tensions and shipping disruptions. The conversation is broadly bullish on the breakout, though some traders warn the rally may be extended and question whether it can hold.

FMC Corp. is an agricultural sciences company, which engages in the provision of solutions to growers and development of pipeline in crop protection, plant health, agriculture, pest control, and turf management. It offers insect control products under the Rynaxypyr and Cyazypyr brands. The company was founded by John Bean in 1883 and is headquartered in Philadelphia, PA.

FMC Corp.

FMCs sharp third-quarter outlook cut, driven by deep pricing adjustments on distributor-held inventory and weak demand, has intensified concerns about its crop-chemicals business, margins and debt. Traders disagree over whether the charges mark a one-time inventory reset ahead of a turnaround or signal deeper deterioration and bankruptcy risk.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Mercks attention centers on Phase 3 results for its partnership with Moderna: the personalized cancer vaccine added to Keytruda reduced melanoma recurrence or death risk, drawing interest in the oncology platform and potential commercial upside. Traders debate whether the results justify further gains, given high expectations, unapproved status, and questions about manufacturing complexity and expansion beyond melanoma.

Anthropic

Anthropics planned mega-IPO and reported financial disclosures are driving attention, with traders weighing rapid Claude revenue growth against heavy infrastructure commitments, losses, and an ambitious potential valuation. Bulls point to enterprise demand and pre-IPO exposure, while skeptics question the spending, competition, and sustainability of the business model.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

PSNY Stock On Track for Fourth Down Week After Analyst Halves Price Cut

Equity

Deutsche Bank cut its price target on Polestar to $10 from $20 on Thursday and kept a Hold rating.


MNDY Stock Falls After Missing Q3 Expectations — Co-CEOs Say Early Results From Restructuring ‘Reinforce Our Conviction’

Monday.com’s third-quarter revenue forecast of $368 million to $370 million missed Wall Street expectations of $373 million.

PSNY Stock Plunges 13% — Polestar Barred From New US Sales Starting 2027, Shifts Focus To Europe

A decision by the Bureau of Industry and Security effectively ends Polestar’s ability to introduce new models in the U.S. market starting next year.


Genius Group Is Shrinking Its Share Count — Here's What Investors Need To Know

At the July 7 AGM, shareholders will vote on a 20% buyback mandate, which will take effect after the current one ends on July 6.

GNS Stock Logs Biggest Intraday Decline In 27 Months On Pricing $8M Offering

Genius Group announced pricing of its stock offering at a discount of 18% compared to the previous closing price.

Polestar Investors Contemplate New And Upcoming Vehicle Lineup’s Strength To Spur A Turnaround  

Polestar is now looking to launch four vehicles in the next three years. 


Why Is GLBE Stock Rising Pre-Market Today?

The company reported adjusted earnings per share of $0.49 in Q4 on revenue of $337 million, compared to expectations of an adjusted EPS of $0.4 on revenue of $328 million, according to TheFly.

Polestar Shares Edge Up After Hours — Retail Eyes ‘Next Leg Up’ In February Strategy Update 

Polestar said retail sales for 2025 came in at 60,119 cars, a 34% growth compared to 2024, marking the company’s best year ever.

Polestar Announces $200M Funding From Geely Chairman’s PSD Investments: Retail Sees Profitability ‘Very Soon’

Polestar has agreed to sell over 190 million newly issued American Depositary Shares to PSD Investment for an aggregate price of $200 million. 


Polestar To Resume Expansion Into New Markets With France, Says Report: Retail’s Still Skeptical

The first showroom in France is expected to open in Le Mans in July, with the initial deliveries slated for October, according to a Reuters report.


iShares Trust - iShares MSCI EAFE Small-Cap ETF

Neutral Sentiment

<ul class="summary-bullets"><li>Deutsche said that Polestar’s growth outlook “remains cloudy.”</li><li>Polestar shares closed 28% lower on September 3, clocking its worst day ever, after the company trimmed its 2026 volume outlook and confirmed it would not fight a U.S. ban on new-model sales.</li><li>Management is now leaning on Europe, which delivered 78% of first-half volume.</li></ul>Shares of EV maker Polestar Automotive Holding UK (PSNY) slumped 6% on Thursday after Deutsche Bank halved its price target on the stock, citing an uncertain outlook.Deutsche Bank cut its price target on Polestar to $10 from $20 and kept a Hold rating, saying the company’s growth outlook “remains cloudy.” The new price target implies a potential upside of 26% from the stock’s last closing price on Wednesday.The Geely-backed electric-car maker’s shares are on track for their fourth consecutive week in the red if the losses hold.<h2 class="st-heading-2">Record Drop After Guidance Cut</h2>Polestar shares closed 28% lower on September 3, clocking its worst day ever, after the company trimmed its 2026 volume outlook and confirmed it would not fight a U.S. ban on new-model sales. First-half deliveries rose only slightly, to 30,423 cars, while revenue fell 4.4% to $1.36 billion. Pricing pressure, weaker carbon-credit sales, and costs tied to the U.S. retreat offset the extra volume. The operating loss narrowed 43% to $629 million, helped by the absence of last year’s large write-downs. Cash stood at about $888 million at the end of June.Management now sees only “low-to-mid single-digit” volume growth for 2026, down from low double-digit growth. CEO Michael Lohscheller blamed “continued market pressure” and a model shift as the Polestar 2 winds down and the Polestar 4 SUV ramps in the fourth quarter.<h2 class="st-heading-2">No Fight Over US Ban</h2>On the earnings call, CEO Michael Lohscheller closed the door on a challenge to the ban on selling its cars in the U.S. “We will not appeal and accept this decision,” he said.Polestar can still sell model-year 2026 cars in the United States but not model-year 2027 vehicles. Service and used-car operations will continue.The U.S. government blocked Polestar from selling new cars in June, starting with the 2027 model year, by denying it a permit under a federal rule that bans cars with software linked to China. After the Commerce Department blocked 2027 models, Polestar said it took “actions relating to employees, dealers and other commercial arrangements.”The U.S. market represented 6% of first-half retail sales, down from 9% in the same period of 2025, CFO Jean-François Mady said. Charges related to the U.S. government decision are estimated at about $130 million, with more possible, he added.Management is now leaning on Europe, which delivered 78% of first-half volume. Polestar is also betting on the Polestar 4 SUV with deliveries starting in the fourth quarter, and a Polestar 2 successor in 2027.<h2 class="st-heading-2">How Did PSNY Retail Traders React?</h2>On Stocktwits, retail sentiment around PSNY remained ‘bullish’ over the past 24 hours, while message volume stayed at ‘extremely high’ levels.A Stocktwits user expects further dilution.<stembedurl>https://stocktwits.com/MesserschmittBavaria/message/663938486</stembedurl>Another user opined that the company’s new CEO could not stop the company's downfall. The company’s current CEO, Lohscheller, took the helm in October 2024, succeeding Thomas Ingenlath.<stembedurl>https://stocktwits.com/Zahrat_Al_Noor_Capital/message/663926125</stembedurl><a href="https://stocktwits.com/symbol/PSNY">PSNY stock</a> has fallen over 60% year-to-date.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/uber-stock-jumps-after-ceo-dara-khosrowshahi-buys-10-million-in-shares/cZtakQ1RJ61">UBER Stock Jumps After CEO Dara Khosrowshahi Buys $10 Million In Shares</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

An electric Polestar vehicle is displayed during the Electrify Expo In D.C. on July 23, 2023 in Washington, DC. (Photo by Nathan Howard/Getty Images)

Deutsche Bank cut its price target on Polestar to $10 from $20 on Thursday and kept a Hold rating.

iShares Core MSCI EAFE ETF

Polestar Automotive Holding UK PLC

iShares MSCI EAFE Small-Cap ETF

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

SCZ iShares MSCI EAFE Small-Cap ETF

Fundamentals

Latest SCZ News